Emanuela Taioli, MD, PhD

img_Emanuela Taioli
DIRECTOR, INSTITUTE FOR TRANSLATIONAL EPIDEMIOLOGY
PROFESSOR | Population Health Science and Policy
PROFESSOR | Thoracic Surgery
Research Topics
Biostatistics, Cancer, Epidemiology, Healthcare, Lung, Obesity, Personalized Medicine, Public Health, Thyroid, Translational Research
Cancer Epidemiology

My research interest and expertise is in the area of cancer epidemiology. I have published widely on environmental carcinogens, cancer and nutrition, and genetic susceptibility to cancer. I am internationally known for my       work in cancer prevention which includes the study of cancer risk factors in healthy populations, cancer predisposing factors, hormone metabolism and genetic susceptibility to environmental exposure; cancer survivorship   and the effect of lifestyles changes on the risk for cancer recurrence and the development of new secondary cancers; health disparity, access to care in minorities, and chronic diseases prevention in the underserved. I am the Director of the Center for the Study of Thoracic Diseases Outcomes and in that capacity I work closely with surgeons, radiologists and immunologists on lung cancer early detection and treatment studies.

MD, University of Milan

PhD, Columbia University School of Arts and Science

Publications

Selected Publications

Asbestos burden in lung tissue from the general population: a systematic review. Silvia D. Visonà, Giovanni Cecchetto, Emanuela Taioli. Environmental Sciences Europe

The effect of delays in cancer surgery due to the COVID-19 pandemic on cancer resectability and postoperative mortality in different tumor entities. Antonia L. Stengler, Jörg Kleeff, Lisa Rieder, James C. Glasbey, Aneel A. Bhangu, Ewen M. Harrison, Ulrich Ronellenfitsch, M. Aldawbali, S. A. L-Ameri, S. Shream, M. Nahshal, R. Alsayadi, M. Alsayadi, A. Almassaudi, M. Al-Shehari, H. Al-Naggar, S. Scasso, J. Laufer, S. Ullrich, M. Sion, N. M. Ruzgar, A. Maiga, A. T. Hawkins, S. N. Zafar, P. B. Schwartz, E. Foley, J. Barrett, T. Aiken, A. Acher, D. Abbott, B. Sumer, J. Caruso, K. Bosler, H. H. Batjer, V. S. Ban, S. G. Aoun, J. Sundaresan, M. San Andrés, M. Mehdi, H. Marwan, G. Kulkarni, B. George, J. Eid, M. Almasri, E. Aigbivbalu, A. Abouassi, U. Sarpel, E. Gleeson, E. Taioli, H. Badr. Discover Oncology

Evaluating quality of colorectal cancer surgery across elective and emergency health systems: secondary analysis of prospective cohort studies in 95 countries. Sivesh K. Kamarajah, Adewale O. Adisa, Ajay Aggarwal, Alazar Berhe, James Glasbey, Ewen Harrison, Parvez D. Haque, Ismail Lawani, Sonia Mathai, Ana Minaya Bravo, C. S. Pramesh, April C. Roslani, Chris Varghese, Aneel Bhangu, Sivesh K. Kamarajah, Adewale O. Adisa, Ajay Aggarwal, Rifat Atun, Alazar Berhe, James Glasbey, Ewen Harrison, Parvez D. Haque, Ismail Lawani, Sonia Mathai, Salome Maswime, Ana Minaya Bravo, CS S. Pramesh, April Camilla Roslani, Nobhojit Roy, Richard Sullivan, Sudha Sundar, Chris Varghese, Aneel A. Bhangu, Sivesh K. Kamarajah, Aneel A. Bhangu, Neil J. Smart, Ana Minaya-Bravo, Jonathan P. Evans, Gaetano Gallo, Susan Moug, Francesco Pata, Peter Pockney, Salomone Di Saverio, Abigail Vallance, Dale Vimalchandran, H. Badr, K. Shah, E. Taioli, E. Gleeson, U. Sarpel. BJS open

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Taioli has not yet completed reporting of industry relationships or has no industry relationships to report.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.